Ticker Symbol: RGLS
Regulus Therapeutics Inc
$0.40 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001505512
Company Profile
Regulus Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in La Jolla, CA.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 10628 Science Center Dr Ste 225
Website: regulusrx.com
CEO: Joseph Hagan
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.37
Change:
-$0.01
(
-0.73%)
Days Range: $1.28 - $1.39
Beta: 1.12
52wk. High: $2.14
52wk. Low: $0.76
Ytd. Change 0.00%
50 Day Moving Average: $1.42
200 Day Moving Average: $1.39
Shares Outstanding: 19484461
Valuation
Market Cap: 2.7B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A